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Abstract
Background: Beta-catenin has two major functions: coordinating cell-cell adhesion by interacting with
cadherin in cadherin junction formation pathway; and regulating gene expression through Wnt signaling
pathway. Accomplishing these two functions requires synergistic action of various sequential regions of
the same beta-Catenin molecule, including the N-terminal tail, the middle armadillo domain, and the
C-terminal tail. Although the middle armadillo domain is the major functional unit of beta-Catenin, the
involvement of tails in the regulation of interaction between beta-Catenin and its partners has been well
observed. Nonetheless, the regulatory processes of both tails are still elusive. In addition, it is interesting
to note that the three sequential regions have different structural features: The middle armadillo domain
is structured, but both N- and C-terminal tails are disordered. This observation leads to another important
question on the functions and mechanisms of disordered tails, which is also largely unknown.
Results: In this study, we focused on the characterization of sequential, structural, and functional features of
the disordered tails of beta-Catenin. We identified multiple functional motifs and conserved sequence motifs
in the disordered tails, discovered the correlation between cancer-associated mutations and functional motifs,
explored the abundance of protein intrinsic disorder in the interactomes of beta-Catenin, and elaborated a
working model on the regulatory roles of disordered tails in the functional pathways of beta-Catenin.
Conclusion: Disordered tails of beta-Catenin contain multiple functional motifs. These motifs interact with
each other and the armadillo domain of beta-catenin to regulate the function of beta-Catenin in both
cadherin junction formation pathway and Wnt signaling pathway.
Keywords: Beta-Catenin, Wnt signaling pathway, Cadherin junction formation, Intrinsic disorder,
Auto-regulation
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Background
Beta-Catenin is a 92-kDa protein that is composed of
two flexible tails at each of the N- and C-termini, and an
intermediate structured armadillo domain (ARM) con-
taining 12 repeats of helical segments [1]. The function
of beta-Catenin is to regulate cadherin junction forma-
tion [2, 3] and to regulate Wnt signaling [4, 5]. There-
fore, beta-Catenin plays critical roles in many biological
processes, such as embryonic development [6, 7], cell
division [8], and maintenance of pluripotency [9]. Dis-
organized expression of beta-Catenin is associated with
many diseases, including cancer [10–12] and cardiovas-
cular diseases [13, 14]. The ARM domain is the major
determinant for the function of beta-Catenin. It binds to
the cytoplasmatic tail of cadherin at the stage of junction
formation. ARM domain also interacts with short motifs
on both Axis Inhibition Protein (Axin) and Adenoma-
tous Polyposis Coli tumor repressor protein (APC) in
Wnt signaling pathway [15]. The interaction raises the
local concentration of beta-Catenin and leads to the
phosphorylation, ubiquitination, and degradation of beta-
Catenin [16]. Upon the activation of Wnt signaling mole-
cules, beta-Catenin molecules escape from the degrad-
ation pathway, accumulate in cytoplasma, and translocate
into nucleus. One possible translocation mechanism
involves the interaction between the ARM domain and
the phenylalanine-glycine(FG)-repeat containing proteins
in the Nuclear Pore Complex (NPC) [17, 18]. Once acces-
sing the nucleus, beta-Catenin uses its ARM domain to
interact with T Cell Factor/Lymphoid Enhancer Factor
(TCF/LEF) family transcription factors to activate down-
stream gene expression [19–21].
The disordered tails of beta-Catenin were also found
to synergistically regulate the function of beta-Catenin
in recent studies. The tails regulate the binding between
beta-Catenin and cadherin [22]. The N-terminal tail of
beta-Catenin is also phosphorylated by the destruction
complex, which is formed by Axin, APC, Casein Kinase
I alpha (CK1-alpha), Glycogen Synthase Kinase 3β
(GSK-3beta), and Protein Phosphatase 2A (PP2A)
[23–25]. Phosphorylated beta-Catenin is ubiquitinated
and then degraded [26–28]. Wnt signaling molecules
outside of the cell are able to prevent the formation
of destruction complex and therefore increase the cyto-
plasmic level of beta-Catenin. In this way, the cytoplasmic
level of beta-Catenin is tightly regulated. The flexible tail
of beta-Catenin also facilitates its nuclear translocation
[29, 30], and recruits factors involved in transcription
activation [31].
These discoveries have extended our comprehension
on the interaction patterns between beta-Catenin and its
partners, and opened a new field on the functional roles
of flexible tails. However, the detailed mechanisms associ-
ated with these new discoveries are still largely unknown.
In this study, we applied systematic bioinformatics
analyses on both N- and C-terminal tails of beta-Catenin,
identified multiple functional motifs, characterized the
conserved sequential segments, discovered the pattern of
interactions between beta-Catenin and its partners,
revealed the correlation between cancer-associated muta-
tions and functional motifs, and proposed possible regu-
latory mechanisms of flexible tails on the function of beta-
Catenin. This study increases our knowledgebase on the
sequential, structural, and functional features of beta-
Catenin tails, facilitates our understanding on the mecha-
nisms and regulatory roles of the terminal tails on the
functions of beta-Catenin.
Method
Sequence analysis
(1) Sequence conservation: The FASTA sequences of
beta-Catenin from different species were extracted from
UniprotKB [32]. The sequences were used as input of
different predictors. The sequences were also aligned
and uploaded to WebLoGo [33] to generate sequence
logo plots to demonstrate the conserved patterns of
amino acids. (2) Mutation analysis: Amino acid substi-
tutions in human beta-Catenin were retrieved from
UniprotKB, COSMIC (Catalogue of Somatic Mutation in
Cancer) [34], DMDM (Domain Mapping of Disease
Mutations) [35], and BioMuta [36] databases. These four
databases have 20, 278, 20, and 138 mutations, respect-
ively. Both of the UniProtKB and DMDM databases
contain one unique mutation that is not found in other
databases. COSMIC and BioMuta have 128 overlapped
mutations. The total number of unique mutations is
281. These mutations were then analyzed in parallel with
functional sites/motifs obtained from motif analysis.
Structural analysis
(1) Secondary structure prediction: NetSurfP [37] was
used to predict the secondary structure of beta-Catenin.
The NetSurfP predictor applied a two-step strategy, of
which the first step was used to predict the secondary
structure of amino acids in three states (helix, strand,
and coil) by using protein sequence as input, and the
second step was a filter by taking the predicted second-
ary structures of the first step over a sliding window as
input. In both steps, artificial neural networks were
applied to make predictive output based on the input
data. (2) Disorder prediction: Both PONDR-FIT [38]
and PONDR©VLXT [39] were applied to predict per-
residue disorder score of beta-catenin. PONDR-FIT is
an artificial neural network based meta-predictor and is
composed of six individual predictors: PONDR©VLXT,
PONDR-VSL2 [40], PONDR-VL3 [41], FoldIndex [42],
IUPred [43], and TopIDP [44]. Since the integration of
individual predictors in the meta-strategy combines all
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the possible correct predictions, the accuracy of
meta-predictor is normally improved significantly. In
fact, PONDR-FIT is one of the most accurate predictors
for protein intrinsic disorder [45]. PONDR©VLXT is
highly efficient in identifying hydrophobic motifs within
long disordered regions. The input features of
PONDR©VLXT include various combinations of amino
acids, mainly hydrophobic residues. For this reason,
PONDR©VLXT is very sensitive to the local changes of
amino acids and can be used to easily detect local hydro-
phobic clusters. In the outputs of both predictors, residues
with score higher than 0.5 were considered to be disor-
dered, residues with score lower than 0.5 were treated as
structured. PONDR-FIT was also used to analyze proteins
in the primary and the secondary interactomes of beta-
Catenin, as well as proteins in the related signaling
pathways.
Functional analysis
(1) Binding Motifs: ANCHOR [46], MoRF [47], and
MoRFpred [48] were used to predict potential binding
motifs inside disordered regions. ANCHOR identifies
binding motifs that are dependent on hydrophobic clus-
ters, MoRF is able to detect binding motifs that undergo
structural transition from coil to helix, and MoRFpred
finds binding motifs that change conformations from
coil to helix, strand, and other types of coils. (2) Linear
Motifs: ELM [49] online server was applied to predict
possible functional linear motifs. ELM contains short
linear motifs that normally stretch over three to ten resi-
dues. The ELM motifs have broad functions, including
cleavage, binding, modification, etc. (3) Protein Inter-
action Networks and Pathways: The protein-protein
interaction networks were collected from the STRING
database [50] by using confidence score 0.85. STRING
is one of the most comprehensive databases for protein-
protein interactions. Proteins signaling pathways were
extracted from KEGG [51], which is a prevailing tool for
the scientific community. The gene names/protein IDs
from STIRNG and KEGG were also used to extract corre-
sponding protein sequences from UniProtKB. (4)
FATHMM (Functional Analysis Through Hidden Markov
Models) [52]: FATHMM is an advanced high-throughput
predictor trained by using hidden Markov model on
multiple mutation databases for analyzing the functional
impacts of mutations. FATHMM outperformed many
other predictors on multiple validation datasets. All the
mutations were then classified by FATHMM using two
independent variables (criteria): Damaging (or Tolerant)
and Cancer-promoting (or non-Cancer-promoting), into
four groups: Damaging and Cancer-promoting, Damaging
and non-Cancer-promoting, Tolerant and Cancer-
promoting, and Tolerant and non-Cancer-promoting.
Results
Disordered tails at both N- and C-termini accommodate
predicted binding motifs
PONDR-FIT [38], which is one of the most accurate
predictors of protein intrinsic disorder [45], was applied
to identify disordered regions of beta-Catenin. The
prediction of PONDR-FIT as shown in the upper panel
of Fig. 1 demonstrates that: (1) the middle region of
human beta-Catenin from ~AA130 to ~ AA710 is struc-
tured; and (2) the N- and C-terminal tails flanking the
middle region are disordered. These conclusions are
supported by the prediction of PONDR©VLXT [39]
predictor as shown in the lower panel of the same figure.
The disorder curve of PONDR©VLXT prediction is
more fluctuating due to the fact that this predictor is
very sensitive to local composition of amino acids. Even
though, the disorder scores of the middle region from ~
AA220 to ~ AA600 are much lower than that of the
flanking tails, indicating the conformation of the middle
region is much more rigid than the flanking tails. In
addition to the consistency between different computa-
tional predictors, the conclusions on structural flexibility
of beta-Catenin are also supported by experimental
results. In a recent x-ray crystallography study, the struc-
ture of beta-Catenin was resolved for a region spanning
from AA138 to AA691 [1], which is similar to the
above-mentioned structured region identified by both
PONDR-FIT and PONDR©VLXT. This region contains
an armadillo domain of which the structure is deter-
mined to be twelve repeats of helical segments as shown
on the top of Fig. 1. Regions other than this armadillo
domain failed to be crystallized, indicating the presence
of considerable structural flexibility in these regions.
These results come to a consistent conclusion that the
armadillo domain has inflexible 3D structure, while both
tails are disordered. For the simplicity of discussion in
this study, N-terminal and C-terminal tails of human
beta-Catenin were defined as AA1-AA150 and AA667-
AA781, respectively.
The lower panel of Fig. 1 shows: (1) the disorder
prediction of PONDR©VLXT predictor, (2) the secon-
dary structure prediction from NetSurfP [53], which is
one of the most accurate and popular predictors of
protein secondary structure, and (3) binding motifs iden-
tified by Molecular Recognition Feature (MoRF) [47],
MoRFpred [48], and ANCHOR [46], respectively. MoRF
predicts binding motifs that change their conformations
from coils to helices upon binding, MoRFpred identifies
binding motifs that transform from coil into one of the
three basic secondary structures (helix, strand, and coil),
and ANCHOR recognizes interaction motifs dominated
by hydrophobic residues. The disorder curves of
PONDR©VLXT prediction at both tails display multiple
“dip” regions, which indicate hydrophobic clusters of
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amino acids inside disordered regions. The segments
corresponding to these dips often function as binding
motifs. Secondary structure prediction demonstrates that
the central ARM domain is composed of many helical
segments, the N-terminal tail has multiple scattered
helical segments, but the C-terminal tail has only a couple
of helical segments in the first ~40 residues and is
depleted of helices in the rest ~80 residues. The predicted
binding motifs were shown as short bars in the lower
panel of Fig. 1. At the N-terminal end (AA1 ~AA150) of
the disorder curve, all three dips (at ~ AA25, ~AA80, and
~AA130, respectively) are overlapped with binding motifs
predicted by at least two predictors. At the C-terminal
end (over ~ AA660), the segment corresponding to a
composite dip at ~ AA760 was predicted to be a binding
motif by three predictors. Another two segments next to
the dip at ~ AA720 were predicted to be binding motifs by
ANCHOR. The forth segment overlapped with the dip at
~ AA660 was predicted as binding motif by MoRFpred.
All the predicted binding motifs, except the last two
(~AA720 and ~ AA760) that locate at the very end of
C-terminal tail, are also predicted to be helices.
Disordered tails are enriched of linear motifs
Eukaryotic Linear Motifs (ELMs) are short sequence
motifs of normally several amino acids, but perform
multiple types of functions [49]. By searching ELM
database [49], 130 ELMs were identified in beta-Catenin.
In which, 73 ELMs locate in the tail regions (Additional
file 1: Table S1). Figure 2a shows the density of each type
of ELMs in the middle domain and the tail regions of
beta-Catenin. It is clear that the densities of different types
of functional motifs in both tails are much higher than
that in the ARM domain. Both tails are extremely
enriched of MOD and LIG motifs. In addition, while only
the N-terminal tail has DEG motifs, the C-terminal tail
has many more MOD and DOC motifs. To demonstrate
the sequential distribution of motifs, the locations of a
non-redundant set of ELM motifs in the tail regions were
labeled for both N-terminal and C-terminal tails in Fig. 2b
and c. At the N-terminal tail, ELM motifs cluster at three
locations: ~AA20, ~AA70, and ~AA120. In the C-
terminal tail, the motifs congregate at ~ AA675, ~AA720,
and ~AA760. Clearly, these locations are essentially the
same as the dips and binding motifs predicted in Fig. 1.
Fig. 1 Predicted intrinsic disorder of and predicted binding motifs in human beta-Catenin (UniProtKB Entry: P35222). X-axis shows sequential indexes
of amino acids. Y-axis displays disorder scores predicted by PONDR-FIT (upper panel) and PONDR©VLXT (lower panel). Residues with score higher than
0.5 are disordered, otherwise structured. In addition, residues with score between ~0.3 and 0.5 are assumed to be flexible, and residues with score close
to zero are extremely rigid. The gray shadow behind PONDR-FIT prediction is the estimated prediction error from PONDR-FIT predictor. Horizontal blue
bars in the upper panel represent the domain structure of twelve armadillo repeats. Dark cyan bars in the middle of lower panel are helices predicted
by NetSurP. Binding motifs were predicted by MoRF (dark yellow), ANCHOR (brown), and MoRFpred (dark green) predictors, respectively. The 3D
structure for the armadillo domain of human beta-Catenin (PDB id: 1JDH) was placed on the top of the figure
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Among these predicted motifs, six have been experi-
mentally validated: The MOD_GSK3_1 motif (AA30-37)
is phosphorylated by GSK3-beta [54–56]; The ubiquitin
ligase binding motif DEG_SCF_TRCP1_1 (AA32-37)
recognizes F box in SCF (beta-TrCP1) for subsequent
ubiquitination [57]; DOC_WW_Pin1_4 (AA243-248) on
beta-Catenin interacts with prolyl somerase Pin1 [53];
MOD_PKA_1 motifs (AA549-555 and AA672-678) are
phosphorylated by PKA kinase [58]; and the PDZ-binding
motif LIG_PDZ_Class_1 (AA776-781) forms complex
with TIP-1 [59].
Weblogo analyses in Fig. 2b and c present multiple
sequential patterns and sequence motifs that are con-
served cross eight species (Additional file 2: Table S2).
Most notably, AA90 ~ AA130 at N-terminal tail and
AA774 ~ 781 at the very end of C-terminal tail accom-
modate highly conserved motifs. Other regions may not
contain highly conserved consecutive amino acids
sequences, but do have highly conserved patterns of
amino acids. To name a few, both AA670 ~ AA680 and
AA730 ~ AA740 have conserved hydrophobic patterns.
Although being conserved, many of these segments are
still lack of functional annotations, such as AA90 ~
AA100, AA140 ~ AA150, AA730 ~ AA740, and AA750
~ AA760.
N-terminal tail is associated with the majority of
sequential variances
Figure 3a shows the sequential distribution of mutations
of beta-Catenin collected from four databases, including
UniProtKB [32], COSMIC [34], DMDM [35], and
BioMuta [36]. Clearly, almost all the deletions and inser-
tions are only observed at the first half of the N-terminal
tail (AA1 ~ AA75). The majority of synonymous and
Fig. 2 ELM motifs in beta-Catenin. a Distribution of six types of ELM motifs in the N-terminal tail, the ARM domain, and the C-terminal tail. The
six types of ELM motifs are: CLV–cleavage site, DEG–degragon, DOC–modifying enzyme docking, LIG–ligand binding, MOD–post-translational
modification site, and TRG–subcellular targeting. The density of each type of ELM motif in each region of beta-Catenin was calculated by firstly normalizing
the number of a specific type of motifs in that region over the total number of ELM motifs in beta-Catenin, and then scaling the result over the length of
that region based on every 100 residues. b and c demonstrate the locations and conservation of ELM motifs in the N- and C-terminal tails, respectively.
Motifs in red are experimentally validated. In both figures, “redundant” motifs that belong to the same functional family or overlap with each other on their
amino acid sequences have been filtered out to keep the clarity and simplicity of the figures. The weblogo plots were built using beta-Catenin sequences
from eight species (Human, Mouse, Bovine, Dog, Turtle, Frog, Jelly fish, and Urchin, see Additional file 2: Table S2)
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missense mutations are also in the first half of the N-
terminal tail, although a small portion do spread along
the entire sequence. More specifically, over 82 % of the
mutations occur in the region from AA1 to AA75, and
over 71 % of the mutations present in a smaller segment
from AA25 to AA75.
Figure 3b presents the mutations and modifications on
both N- and C-terminal tails of beta-Catenin extracted
from UniProtKB, together with the functional motifs
predicted from ELM. The UniProtKB information on
mutation and modification is of high confidence due to
the fact that the information is either experimentally
validated or observed on their homologous sequences.
By comparing the locations of these mutations and
modifications, it is clear that most of them are in the
region from AA25 ~ AA50. The involved amino acid
Fig. 3 Sequence variances in disordered tails. Information on the mutation and modification of beta-Catenin was extracted from UniProtKB, COSMIC,
BioMute, and DMBM. a Occurrences of five different types of mutations. The types of mutations from top to bottom are: (1) missense mutation, (2)
synonymous mutation, (3) in-frame deletion, (4) frameshift deletion, and (5) insertion. X-axis shows the amino acid sequence. Y-axis is the occurrences of
mutations. The plots in (1), (2), and (5) show the number of point mutations at each site. The lines in (3) and (4) represent deleted segments. b Mutations
and post-translational modifications in the N-terminal tail of beta-Catenin. The upper inset shows a non-redundant set of functional motifs at the
N-terminal tail of beta-Catenin. The middle inset demonstrates mutations from UniProtKB for the N-terminal tail and Tyr-654 near the C-terminal tail. Red
bars stand for natural variants and pink bars for mutagenesis sites. The character label “wt” and the numbers at the left-hand side indicate wild type (wt)
and mutations (1, 2, and 3). Lower inset shows observed post-translational modifications in both N- and C-terminal tails
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residues include Ser-23, 33, 37, 45, Trp-25, Asp-32, Gly-
34, Ile-35, and deletion of N’-WQQQSYLDS-C’ (AA25-
33). These mutations overlap with one CLV, two DEG,
one DOC, eight LIG, 12 MOD, and two TRG ELMs
(Additional file 1: Table S1). In terms of functional
influences, Ser-45, Ser-37, and Ser-33 at the N-terminal
tail are three critical residues of which the phosphory-
lation and subsequent ubiquitination lead to the degra-
dation of beta-Catenin [23, 26–28]. Near the C-terminal
tail, several mutations are observed on Tyr-654, which is
also a critical residue that uses phosphorylation to
regulate the interaction between beta-Catenin and cad-
herin [22, 60].
FATHMM was used to evaluate the functional impact
of point mutations as shown in Fig. 4. Figure 4a shows
the sequential distribution of all the point mutations in
four groups. Clearly, almost all the cancer-promoting
mutations are located in the N-terminal tail of beta-
Catenin, and non-cancer-promoting mutations are
accommodated in either the ARM domain or the C-
terminal tail. Although seeming to be similar, the distribu-
tions of mutations in the first group (damaging and
cancer-promoting) and the third group (tolerant and
cancer-promoting), as well as the distribution of muta-
tions in the second group (damaging and non-cancer-
promoting) and the fourth group (tolerant and non-
cancer-promoting) are significantly different (P-values of
F-test are 2.4e-11 and 1.2e-8, respectively). In addition,
the frequencies of mutations at various sites in the N-
terminal tail in the first group (damaging and cancer-
promoting) are several times higher than the frequencies
in other groups and regions. Figure 4b presents the
change of structural flexibility caused by point mutation at
three different regions in four different groups. Again,
from the top and middle panels, it can be seen that the
mutations at the N-terminal tail are cancer-promoting
and are associated with large variations of structural flexi-
bility. Meanwhile, the mutations at the C-terminal tail are
non-cancer-promoting and are demonstrated by very
limited variations of structural flexibility. In the bottom
panel, it is clear that the damaging associated mutations
may have large variations of structural flexibility, but the
tolerant-associated mutations have relatively small
changes of structural flexibility.
Structural flexibility in the interaction partners of
beta-catenin
Beta-Catenin interacts with its partners using its struc-
tured ARM domain and/or its flexible tails. Out of a
total of 24 PDB structures for complexes formed
between beta-Catenin and its partners, five are formed
between the tails of beta-Catenin and the structured
domains of other proteins, 18 complexes are formed
between the structured ARM domain of beta-Catenin
and the short segments of other proteins, the last one
complex is formed between the ARM domain of beta-
Catenin and a structured domain of another protein
Fig. 4 Correlation between functional variations and point
mutations at different regions. By using FATHMM, all the mutations
were assigned into one of the four groups based on two
independent criteria: Damaging (or Tolerant) and Cancer-promoting
(or non-Cancer-promoting). a Distribution of point mutations along
the amino acid sequence of beta-Catenin in four groups (from top
to bottom): Damaging and Cancer-promoting; Damaging and
non-Cancer-promoting; Tolerant and Cancer-promoting; and
Tolerant and non-Cancer-promoting. Y-axis shows the frequency of
mutations at each sequential site. b Quartile distribution plot on the
variation of structural flexibility caused by point mutation in
afore-mentioned four groups of mutations (x-axis) for three different
regions of beta-Catenin (top: the N-ter tail; middle: the C-ter tail; and
bottom: the ARM domain). The structural flexibility was characterized
using disorder score predicted by PONDR-FIT. The variation of
structural flexibility at a specific site was calculated as the ratio of
the change of disorder score at that site caused by the mutation to
the disorder score at the same site of the wild-type sequence
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LRH-1 (Additional file 3: Table S3). In the first five
complexes, disordered tails of beta-Catenin are involved.
In the next 18 complexes, the short segments of the
partners are either disordered or inside disordered
regions. Therefore, 23 out of 24 interactions between
beta-Catenin and its partners involve intrinsically dis-
ordered regions.
To determine the abundance of protein intrinsic
disorder in the protein interaction networks of beta-
Catenin, we retrieved interaction partners of beta-
Catenin from the STRING database [50] (Additional file
4: Table S4). STRING is a comprehensive database of
protein-protein interactions with multiple choices of
functional annotations and source of interactions.
Figure 5a illustrates the distribution of protein intrinsic
disorder in the interaction network of beta-Catenin. Out
of 39 interaction partners of beta-Catenin, 14 proteins
were predicted to be disordered, seven were predicted to
carry large portion of disordered regions, and 18 were
predicted to have small portion of disordered residues
and therefore structured. Out of these 18 structured
proteins, four cadherin-family members (CDH1, 2, 3,
and 5) and a transcription factor LEF-1 use their flexible
segments to bind the ARM domain of beta-Catenin
(Additional file 3: Table S3). UBC, CUL1, FBXW11, and
BTRC are proteins associated with ubiquitin ligase
complex, which interacts with the N-terminal tail of
beta-Catenin [28]. The other seven proteins are kinases,
phosphatases, and deacetylase. These enzymes frequently
target amino acids on the tails of beta-Catenin. In fact, as
shown in Fig. 3, two groups of amino acids on or near the
flexible tails of beta-Catenin undergo critical modifi-
cations: one group includes Ser-45, Thr-41, Ser-37, and
Ser-33, which can be phosphorylated by CKI-alpha and
GSK-3beta; the other group contains Tyr-654 that can be
phosphorylated by CSK. The modifications on these two
groups of amino acids regulate the function of beta-
Catenin in the Wnt signaling pathway and the cadherin
junction formation pathway, respectively [22, 23, 26–
28, 60]. This observation agrees to the conclusions of
our previous studies in which structural flexibility is
found to be one of the determinants of amino acid
modifications [61, 62].
Figure 5b shows the abundance of protein intrinsic
disorder in the secondary interactome of beta-Catenin,
which includes all the proteins that interact with the
protein(s) in the first interactome of beta-Catenin. All
the proteins in the secondary interactome were grouped
by their interacting partners in the first interactome. In
these groups, 23 have 10 or less partners in the secon-
dary interactome, 15 have more than 10 but less than
100 partners, and only one protein (UBC) has about 500
interaction partners. Altogether, the total number of
proteins in the secondary interactome is 1010. To show
the abundance of intrinsic disorder, we used both the
fraction of disordered residues and the total number of
disordered residues because the interaction partners may
have large variance in size. In fact, in the first interactome
of beta-Catenin, two are short proteins (CTNNBIP1 and
SKP1) of about 100 residues, four (APC, CREBBP, CDH8,
and TRRAP) are large proteins with more than 2000
residues, and the rest 33 have from hundreds to a little
Fig. 5 a Interaction partners of beta-Catenin (CTNNB1). The interaction
partners were extracted from the STRING database using threshold
value 0.85. The colors of the symbols indicate the fraction of disordered
residues in that protein, categorized into three groups: blue (0–30 % of
residues are intrinsically disorder), pink (30–50 %), and red (>50 %). The
shapes of the symbols specify the number of interaction partners of
that protein: Circle - less than five partners; Hexagon - more than five
interaction partners. Lines between proteins imply that these two
proteins interact with each other. b Abundance of intrinsic disorder in
the secondary interactome of beta-Catenin. The secondary interactome
refers to all the proteins that interact with one of the interaction
partners of beta-Catenin. X-axis presents proteins in the first
interactome shown in (A). All the proteins were ranked based on the
fractions of disordered residues, with (I), (II), and (III) corresponding to
the red, pink, and blue groups in (A), respectively. The first Y-axis on
left-hand side shows the number of residues in each protein (gray bar)
and the number of disordered residues in each protein (pink bar). The
second Y-axis on the right-hand side uses stacked bars to show the
distribution of intrinsic disorder in all the interaction partners of that
protein indicated on X-axis. From bottom to top, the bars indicate
number of proteins with 0–30 % of disordered residues (dark gray),
number of proteins with 30–50 % of disordered residues (green), and
number of proteins with more than 50 % of disordered residues
(dark green). Both the first and the second Y-axes use base-10 log scale
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more than 1000 residues. After using both measures, it
can be seen that most of the interaction partners in the
secondary interactome have either higher ratio of disor-
dered residues or higher absolute number of disordered
residues. Only in the last five groups on the x-axis (CDH1,
RUVBL1, FBWX11, RUVBL2, and UBC), the proteins
have smaller portions of interaction partners that have
both high fraction and high absolute number of disor-
dered residues. In conclusion, the majority of the proteins
in the secondary interactome have significant amount of
disordered residues.
Disordered tails regulate the function of beta-Catenin
Beta-catenin is predominantly involved in two pathways:
the cadherin junction formation pathway and the Wnt
signaling pathway. The major component molecules in
these two pathways at different subcellular locations
were presented in Fig. 6a. Many proteins associated with
the Wnt signaling pathway have large fraction of disor-
dered residues and therefore are labeled in red. Figure 6b
describes the functional roles of disordered tails at five
representative stages in both of the afore-mentioned
pathways. In this figure, stages (a) and (b) correspond to
the cadherin junction formation pathway. Stages (c), (d),
and (e) are related to the Wnt signaling pathway.
In the cadherin junction formation pathway, cadherin
interacts with ARM domain on a region spanning from
the 12th to the 7th armadillo repeats [2]. This inter-
action is enhanced by the association between the N-
Fig. 6 Disordered tails regulate the function of beta-Catenin in two
pathways. (A) Key players in the cadherin junction formation pathway
and the Wnt signaling pathway. Proteins in red color are intrinsically
disordered, while proteins in blue color are basically structured.
Beta-Catenin was shown in dark blue to be differentiated from other
proteins. Cadherin was shown in apricot due to its large amount of
intrinsically disordered residues. (B) Regulatory roles of disordered tails
on the functions of beta-Catenin in both cadherin junction formation
and Wnt signaling pathways. ARM is the armadillo domain of
beta-Catenin. N-ter and C-ter stand for the N-terminal and C-terminal
tails of beta-Catenin. (a) – (e) represent five different functional stages
of beta-Catenin. “P” indicates phosphorylation. “FG” stands for
phenylalanine-glycine(FG)-repeat containing proteins in the nuclear
pore complex. “NTM” refers to nuclear translocation motif. The
destruction complex is composed of CKI-alpha, GSK-3beta, Axin, and
APC. (C) Conserved sequential patterns among mouse cadherin
(UniPortKB Entry: P09803, AA813-834), human cadherin (UniPortKB
Entry: P12830, AA811-832), mouse beta-Catenin (UniProtKB Entry:
Q02248, AA751-781), and human beta-Catenin (UniPortKB Entry:
P35222, AA751-781). (D) Pocket formed by AA400-663 (PDB id: 1JDN).
Blue: positive charged residues; Red: negative charge residues; Gray:
hydrophobic residues; Light yellow: other residues. (E) Change of the
direction of the line formed between the oxygen atom on the side
chain of Tyr654 and the Cα atom of Tyr432 in two PDB structures
(Blue: PDB 2Z6H; Apricot: PDB 1QZ7). The angle associated with the
change of the direction implies the structural variation of the binding
pocket. The RMSD calculated from these two structures for the
segment from AA576 to AA685 is 0.75 angstroms
The Author(s) BMC Genomics 2016, 17(Suppl 5):484 Page 521 of 569
terminal tail and the ARM domain of beta-Catenin [22].
A specific C-terminal segment AA683-AA750 also inter-
acts with the N-terminal tail to facilitate the association
between the N-terminal tail and the ARM domain [22].
Interestingly, a different C-terminal segment of beta-
Catenin competes with cadherin on binding the ARM
domain [22]. Figure 6c shows that a C-terminal segment
on beta-Catenin starting at Leu-753 is highly conserved
to the corresponding binding motif on cadherin. This
newly identified location of the C-terminal segment is
different from previously reported segment that spans
from Gln-760 to the end of beta-Catenin [22]. Besides
the competing interactions among different regions, the
phosphorylation of Tyr-654 that is close to the C-
terminal tail eliminates the interaction between cadherin
and the ARM domain of beta-Catenin [22]. These
complex regulatory roles of disordered tails of beta-
Catenin are illustrated in (a) and (b) of Fig. 6b.
The contacting residues on the interface between hu-
man cadherin and human beta-Catenin include: Ile811,
Leu815, Asp819, Pro826, Tyr827, Asp828, Ser829, and
Leu831 on cadherin, and Ala656, Tyr654, Asn516,
Arg474, His470.Tyr469, and Asn426 on beta-Catenin
[2]. In which, Tyr-654 on beta-Catenin is critical for the
association between cadherin and beta-Catenin. Its phos-
phorylation disrupts the interaction between cadherin and
beta-Catenin [60, 63, 64]. The phosphorylation also
decreases the affinity between the ARM domain and the
C-terminal tail of beta-Catenin [60]. From a theoretical
point of view, phosphorylation on Tyr-654 changes the
local polarity of the ARM domain, leading to the inter-
actional and functional modifications of the ARM domain.
As shown in Fig. 6d, the interface composed of AA400-
663 on the ARM domain is actually a pocket and is
enriched of charged and hydrophobic residues, of which
the combination is ideal for mediating protein-protein
interaction. In addition, structural comparison of the
ARM domains in two different structures, which are
obtained before and after binding to a motif, shows that
the RMSD value associated with the structural change
between these two structures for the region from AA576
to AA685 is 0.75 angstroms. The direction of the line
formed between the oxygen atom on the side chain of
Tyr-654 and the Cα atom of Tyr432 is changed by 5.1°
after the motif binding. These results may indicate that
the structural variation caused by motif binding is
negligible.
Once the interaction between beta-Catenin and its part-
ners is eliminated, the concentration of free beta-Catenin
in cytoplasma will be increased. The free beta-Catenin
may enter one of two possible processes: (1) the N-
terminal tail of free beta-Catenin undergoes phosphoryl-
ation and ubiquitination that lead to the degradation of
beta-Catenin [1]; (2) free beta-Catenin transports into
nucleus to activate gene expression. These two processes
comprise the Wnt signaling pathway shown in (c), (d),
and (e) of Fig. 6b. At stage (c), CKI-alpha phosphorylates
Ser-45 first and then GSK-3beta phosphorylates Thr-41,
Ser-37, and Ser-33 successively. Therefore, the N-terminal
tail must be free from binding partners for the phosphor-
ylation and subsequent ubiquitination modifications, but
the C-terminal tail may or may not be bound to other
molecules. The phosphorylation process is facilitated by
Axin and APC, which are two large disordered proteins,
through forming a destruction complex by binding beta-
Catenin, CKI-alpha, and GSK-3beta. The disordered
segments in Axin and APC bind to CKI-alpha, GSK-
3beta, and the ARM domain of beta-Catenin. The pres-
ence of Axin and APC is assumed to increase the local
concentration of both enzymes and substrate to accelerate
the reaction [16].
When Wnt molecules are present, the destruction
complex could not be formed. Therefore, beta-Catenin
will accumulate in cytoplasma and transport from
cytoplasma into nucleus as shown at stage (d). Different
translocation mechanisms have been reported. The trans-
location can be either independent of the interaction with
phenylalanine-glycine(FG)-repeats in the nuclear pore
complex [30], or dependent on the interaction between
the ARM domain of beta-Catenin and the FG repeats
[17, 18]. FG repeats in nuclear pore complexes normally
have 200 ~ 400 residues and are intrinsically disordered
[65]. In the process of nuclear translocation, both the C-
ter tail and the ARM domain of beta-Catenin are required
[66]. Once being transported into nucleus, beta-Catenin
will interact with TCF/LEF family proteins to trigger the
transcription of target genes as shown at stage (e).
Although only the ARM domain is required for the asso-
ciation between beta-Catenin and LEF-1 [19–21], both
tails of beta-Catenin are observed to promote the tran-
sactivation of downstream genes [67, 68].
Discussions
Beta-catenin has two major functions: regulating the
formation of cadherin junction and processing Wnt
signaling. These functions are performed synergistically
by incorporating three sequential regions of beta-Catenin,
including the N-terminal tail, the ARM domain, and the
C-terminal tail. The ARM domain is composed of 12
helical segments and forms a structured domain, but both
N- and C-terminal tails are disordered. In this study,
sequential motifs, structural features, mutations, inter-
action partners, and modifications on both tails were
integrated together to characterize the regulatory roles of
the disordered tails. This is for the first time that all the
five different aspects have been taken into consideration
to characterize the regulatory roles of disordered tails of
beta-Catenin.
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Synergy between ARM and tails
Beta-Catenin interacts with its partners using not only
the ARM domain but also the tails. The ARM domain
forms several binding pockets, while the tails contain
multiple predicted binding motifs and ELM linear
motifs. The ARM domain frequently binds to short
flexible motifs of the partners, and the disordered tails
interact with structured domains of the partners. There-
fore, protein intrinsic disorder is very often involved in
the interaction between beta-Catenin and its partners.
Since the interactions involving disordered regions are
often characterized by high-specificity and low-affinity
[69], disordered motifs in the signaling pathways facili-
tate the regulation of the functions.
Functional motifs and sites in tails
Binding motif predictors may be used not only for
identifying binding sites, but also for inferring the
mechanisms of different binding processes since diffe-
rent predictors are designed for different types of bin-
ding motifs. Three binding motif predictors, including
MoRF, MoRFpred, and ANCHOR, were used in this
study. ANCHOR is able to identify binding motifs
composed by mainly hydrophobic residues. MoRF
predicts motifs undergoing coil-to-helix transition upon
binding to partners. MoRFpred identifies motifs asso-
ciated with structural transition from coil to all three
types of secondary structures. The correlation between
binding motifs and secondary structures can be demon-
strated by comparing the binding motifs to the results of
secondary structure prediction from NetSurfP. As shown
in Fig. 1, it is clear that all the predicted binding motifs
in the N-terminal tail have helical structures, while the
binding motifs at the C-terminal tail are not helices. The
structural information of binding motifs can be further
used to infer the structural requirements of binding
events.
The heterogeneous distribution of the ELM motifs
found in the N-terminal and C-terminal tails indicates
different functional roles of the tails. All DEG motifs
locate in the N-terminal tail. Therefore, the N-terminal
tail is the only region responsible for the ubiquitination
and degradation of beta-Catenin. Actually, the degra-
dation process of beta-Catenin has been well characte-
rized. The phosphorylation of serine and threonine
residues on the N-terminal tail is the prerequisite of sub-
sequent ubiquitination and degradation of beta-Catenin
[23, 27]. The C-terminal tail has more DOC and MOD
motifs than the N-terminal tail does. The coincident
abundance of both DOC and MOD motifs in the C-
terminal tail is expected and consistent, since the DOC
motifs function in binding modifying enzymes, and the
MOD motifs refer to modification sites. Therefore, the
C-terminal tail may undergo many more modification
events.
The C-terminal tail of beta-Catenin contains two
neighboring segments that have contradictory functions.
AA683-AA750 interacts with the N-terminal tail to
facilitate the binding between the N-terminal tail and
the ARM domain, and to further facilitate the inter-
action between beta-Catenin and cadherin. AA753-
AA781, which is right after the previous motif, compet-
ing with cadherin on the interaction with the ARM
domain. Since these two segments have well conserved
sequential patterns and are enriched of functional
motifs, it is expected that additional partners may be
involved in the regulation of the interaction between
these two motifs and the ARM domain.
Tyr-654 is a critical residue in regulating the inter-
action between the C-terminal tail and the ARM domain
of beta-Catenin, as well as the interaction between beta-
Catenin and cadherin. The spatial position of Tyr-654 is
at the mouth of the binding pocket formed by the 7th to
the 12th armadillo repeats. Therefore, when the pocket is
occupied by a binding motif, the accessible surface area
of Tyr-654 will be decreased significantly. By taking into
consideration that the structural variation associated
with motif binding is minor, it can be concluded that the
phosphorylation of Tyr-654 is unlikely to occur when a
binding motif is present, indicating the phosphorylation/
dephosphorylation of Tyr-654 has to occur in the
unbound state. Therefore, the pre-binding modification
of Tyr-654 regulates the interaction between the ARM
domain and its binding partners.
Mutations on tails
High substitution rate is often observed in disordered
proteins and regions. However, although both of the N-
and C-terminal tails of beta-Catenin are disordered, they
contain multiple conserved motifs (i.e., AA90 ~ AA130
in the N-terminal tail and AA774 ~ 781 in the C-terminal
tail) and conserved sequential patterns (e.g., AA670 ~
AA680 and AA730 ~AA740). These conserved regions
actually overlap with predicted binding motifs and ELM
linear motifs, indicating the conservation of functions.
Even though, many segments with conserved amino acids
or sequential patterns are still lack of functional anno-
tation. AA90 ~AA100 and AA140 ~AA150 are two
conserved motifs in the N-terminal tail. Both motifs are
characterized as composites of hydrophobic residues and
charged residues, with positive charged residues in the
first motif and negative charged residues in the second
motif. AA730 ~AA740 and AA750 ~AA760 are another
two C-terminal segments with conserved sequential
patterns involving hydrophobic, positively charged, and
negatively charged residues on each of them.
The Author(s) BMC Genomics 2016, 17(Suppl 5):484 Page 523 of 569
Almost all the cancer-associated mutations on beta-
Catenin are found in the N-terminal tail region, in which,
over 70 % of the mutations locate in a short segment of 50
residues (AA25-AA75) at the N-terminal tail. This region
accommodates Ser-45, Thr-41, Ser-37, and Ser-33, which
are four critical residues in the Wnt signaling pathway. The
phosphorylation of these four residues initiates the degrad-
ation of beta-Catenin. Therefore, it is conceivable that the
mutations in this short region may eliminate the tight
control on the degradation of beta-Catenin. Consequently,
accumulated beta-Catenin turns on the expression of
down-stream genes. In addition, the mutation in this short
segment may also affect the function of beta-Catenin in the
cadherin function formation pathway. In this pathway, the
N-terminal tail of beta-Catenin interacts with the ARM
domain to facilitate the interaction between beta-Catenin
and cadherin. As shown in Figs. 1, 2b, and Additional file 1:
Table S1, the N-terminal tail of beta-Catenin has three
candidate binding motifs, locating at ~AA25, ~AA80, and
~AA130, respectively. The motif at ~AA130 is sequentially
next to the ARM domain. It is unlikely that this motif is
able to “fold back” to interact with the ARM domain. As a
result, only the motifs at ~AA25 and ~AA80 may perform
the function of interacting with the ARM domain. There-
fore, the afore-mentioned mutations in the region of
AA25-AA75 may also abolish the interaction between the
N-terminal tail and the ARM domain.
Conclusions
Disordered tails of beta-Catenin interact with each other
and the ARM domain to regulate the function of beta-
Catenin synergistically. The tails contain many func-
tional motifs. The types of motifs on both tails are sig-
nificantly different, indicating divergence of their
functional roles. Modifications on or near these motifs
further modulate the function of the entire molecule.
Mutations in tails are very often associated with diseases.
Thorough characterization of the functional motifs in
the tails helps further studies on the regulatory mecha-
nisms of beta-Catenin.
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